TABLE 2.
No. of Patients (%)a |
||||
Histologic type | Overall, N = 14363 | LN negative, N = 10302 | LN positive, N = 4061 | P |
Transitional cell carcinoma | 13078 | 9422 (72.0) | 3656 (28.0) | <0.001 |
Squamous cell carcinoma | 598 | 435 (72.7) | 163 (27.3) | |
Adenocarcinoma | 215 | 144 (67.0) | 71 (33.0) | |
Small cell carcinoma | 169 | 109 (64.5) | 60 (35.5) | |
Neuroendocrine carcinoma | 53 | 35 (66.0) | 18 (34.0) | |
Signet ring cell carcinoma | 85 | 35 (41.2) | 50 (58.8) | |
Pseudosarcomatous carcinoma | 45 | 37 (82.2) | 8 (17.8) | |
Other histology | 120 | 85 (70.8) | 35 (29.2) |
LN, lymph node; PLDN, pelvic lymph node dissection.